SARTORI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 5.415
EU - Europa 2.076
AS - Asia 1.266
OC - Oceania 19
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 7
Totale 8.805
Nazione #
US - Stati Uniti d'America 5.390
CN - Cina 856
UA - Ucraina 608
IT - Italia 338
DE - Germania 323
PL - Polonia 304
HK - Hong Kong 298
FI - Finlandia 181
IE - Irlanda 134
GB - Regno Unito 88
FR - Francia 46
VN - Vietnam 28
SG - Singapore 26
CA - Canada 23
SE - Svezia 22
AU - Australia 18
IN - India 15
TR - Turchia 12
EU - Europa 11
BE - Belgio 10
MU - Mauritius 6
NL - Olanda 5
GR - Grecia 4
IL - Israele 4
AE - Emirati Arabi Uniti 3
BR - Brasile 3
JP - Giappone 3
KR - Corea 3
LK - Sri Lanka 3
BD - Bangladesh 2
CL - Cile 2
EG - Egitto 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
MK - Macedonia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
ID - Indonesia 1
IR - Iran 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RU - Federazione Russa 1
SN - Senegal 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 8.805
Città #
Fairfield 783
Woodbridge 714
Jacksonville 452
Chandler 377
Houston 371
Ashburn 347
Seattle 315
Warsaw 303
Cambridge 299
Hong Kong 292
Wilmington 259
Princeton 248
Ann Arbor 238
Beijing 146
Nanjing 145
Dublin 134
New York 130
Dearborn 112
Helsinki 112
Brescia 84
Nanchang 67
Shanghai 62
Des Moines 58
Shenyang 58
Changsha 48
Jinan 47
San Diego 47
Jiaxing 38
Tianjin 37
Hebei 34
Milan 30
Kunming 27
Taizhou 25
Dong Ket 22
Rome 21
Toronto 21
London 20
San Francisco 20
Guangzhou 18
Verona 17
Hangzhou 16
Zhengzhou 16
Lanzhou 14
Ningbo 11
Brussels 10
Boardman 9
Lancaster 9
Los Angeles 9
Monmouth Junction 8
Norwalk 8
Haikou 7
Leawood 7
Fuzhou 6
Kilburn 6
Melbourne 6
Orange 6
Vimercate 6
Falkenstein 5
Gunzenhausen 5
Ho Chi Minh City 5
Meda 5
Sydney 5
Taiyuan 5
Augusta 4
Cazzago San Martino 4
Central 4
Changchun 4
Chicago 4
Chiswick 4
Falls Church 4
Nardò 4
Tel Aviv 4
Turin 4
Washington 4
Acton 3
Baltimore 3
Bari 3
Bonn 3
Canberra 3
Chengdu 3
Colombo 3
Delhi 3
Hefei 3
Islington 3
Kochi 3
Lappeenranta 3
Paris 3
Phoenix 3
Prevalle 3
Redwood City 3
San Jose 3
San Mateo 3
São Paulo 3
Vicenza 3
Villazzano 3
Viterbo 3
Almere Stad 2
Amman 2
Athens 2
Barlassina 2
Totale 6.880
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 282
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 218
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 146
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 140
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 135
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 132
Laparoscopic management of a large urethral leiomyoma 130
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 127
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 125
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 125
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 125
Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study). 122
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 113
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 110
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities. 108
Adnexal torsion with normal ovary in the third trimester of a twin pregnancy: Case report and literature review 108
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 106
Analysis of the evolution in the management of endometrial cancer in Italy: a CTF study. 105
Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study). 102
Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy andradical surgery? An Italian multicenter retrospective study. 100
Early stage cervical cancer: adjuvant treatment in negative lymph node cases. 99
Fetal anemia: Diagnosis and management 99
New development of the FIGO staging system. 98
Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors 98
Androgens, insulin-like growth factor-I (IGF-I), and carrier proteins (SHBG, IGFBP-3) in postmenopause. 98
Parametrial endometriosis with ureteral involvement: A case report of a conservative approach without ureteral resection 98
Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study) 94
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression. 94
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 94
Endometrial stromal sarcoma: analysis of treatment failures and survival 93
The use of ultrasound-indicated cerclage or cervical pessary in asymptomatic twin pregnancies with a short cervix at midgestation 93
Palliative care in advanced ovarian cancer patients with bowel obstruction 92
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. 91
Identification of a new mutation in the SRY gene in a 46,XY woman with Swyer syndrome. 91
Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study. 91
Twin reversed arterial perfusion sequence: current treatment options 90
An analysis of approaches to the management of endometrial cancer in North America: a CTF study 89
Cancer in pregnancy: Proposal of an italian multicenter study. gynecologic oncology group of the italian society of gynecology and obstetrics (sigo) 88
Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. 87
An Analysis of approaches to th treatment of endometrial cancer in western Europe: a CTF study 87
Prognostic factors in early-stage ovarian cancer. 87
Role of HPV DNA, HPV mRNA and cytology in the follow-up of women treated for cervical dysplasia. 86
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. 85
The role of HE4 in ovarian cancer follow-up: a review. 85
Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis. 83
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 83
Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study. 81
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 81
Follow-up strategies in gynecological oncology: searching appropriateness. 80
Management of borderline ovarian tumors: results of an italian multicenter study 80
Neoadjuvant platinum-based chemotherapy followed by radical hysterectomy for stage Ib2-IIb adenocarcinoma of the uterine cervix – An Italian multicenter retrospective study 77
Insulinoma Identified in Puerperium: Association with Pregnancy and Literature Review 76
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 74
Cancer in pregnancy: maternal and fetal implications on decision-making. 71
Bowel obstruction and survival in patients with advanced ovarian cancer: analysis of prognostic variables. 70
Patterns of Recurrence and Clinical Outcome of Patients with Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response after Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study 69
Learning climate and quality of postgraduate training in gynecology and obstetrics should be assessed in italian training courses 69
Analysis of failure after negative second look in patients with advanced ovarian cancer: an italian multicenter study 68
Retest positive for SARS‐CoV‐2 RNA of recovered pregnant women with COVID‐19 68
Are surveillance procedures of clinical benefit forpatients treated for ovarian cancer?: A retrospective Italian multicentric study. 67
Cancer in Pregnancy: safety of chemotherapy on fetal outcome 62
Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study 62
Analysis of failures and clinical outcome of advanced epithelial ovarian cancer in patients with microscopic residual disease at second-look reassessment following primary cytoreductive surgery and first-line platinum-based chemotherapy. 62
Adiponectin modulation by hyperandrogenism and insulin-resistance in polycystic ovary syndrome and normal women 61
Surveillance procedures for patients with cervical carcinoma: a review of the literature. 61
Surveillance procedures for patients for cervical carcinoma: a review of the literature. 59
Surveillance procedures for patients treated for endometrial cancer: a review of the literature. 56
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 56
The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases 55
Anti-Mullerian hormone (AMH): Prognostic value in assisted reproductive technology (ART) 55
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patiants with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collqaborative Study 54
An analysis of different approaches to ovarian cysts in Italy. 54
Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses 54
Relationship between time interval from primary surgery to the start of taxane- plus platinum – based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: result of a multicenter retrospective italian study 53
Clinical review of 55 cases of malignant ovarian germ cell tumors. 53
Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study. 53
Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis. 53
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 52
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 52
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 52
Approcio anatomo clinico alla patologia dell'uteroin Diagnostica per immagini dell'apparato urogenitale 50
Pretreatment platele and hemoglobin levels are neither predictive non prognostic variables for patients with locally advanced ccervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study 50
Ploidy and S-phase fraction as possible prognostic factors in endometrial carcinoma: a review of 52 cases. 49
Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert 49
Pre-chemoterapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who recwivwe a first-line taxane/platinum-based regimen: results of a multicenter retrospective italian study. 49
Women with severe mutations in the gene 21α-hydroxylase do not express the characteristics phenotype after precocius diagnosis and treatment 48
Clinical review of 63 cases of sex cord stromal tumors. Eur J Gynaecol Oncol. 2004;:431-8. Review. PubMed PMID:15285297 48
A case of combined aortic bioprosthetic valve degeneration and patient-prosthesis mismatch during pregnancy: decision-making and implications after pregnancy. 48
Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian mulicenter retrospective analysis 47
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 46
Clear cell endometrial cancer: a CTF multicentre Italian study 45
SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta 45
Maternal hemodynamics, arterial stiffness and elastic aortic properties in twin pregnancy 45
I tumori epiteliali dell'ovaio: percorsi clinici 44
null 44
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 43
Possible role of palliative surgery for bowel obstruction in advanced ovarian cancer patients 42
Percorsi Clinici in Ginecologiua Oncologica 40
Early Intraperitoneal Transfusion for Fetal Hydrops Caused by Parvovirus B19 Infection 39
The clinical outcome of epithelial ovarian cancer patients withapparently isolated lymph node recurrence: a multicenter retrospective Italian study. 38
Totale 8.091
Categoria #
all - tutte 49.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.165


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019262 0 0 0 0 0 0 0 0 0 0 0 262
2019/20202.145 286 62 60 223 116 257 236 229 134 329 82 131
2020/20211.645 33 146 46 186 61 206 80 195 197 246 169 80
2021/20221.103 71 197 20 50 19 30 101 85 65 107 102 256
2022/20231.070 157 39 48 51 92 268 12 117 158 6 63 59
2023/20241.033 88 27 94 104 46 183 73 57 304 32 20 5
Totale 8.984